Thank you.
Dr. Langley, I want to pursue the issue of some of the Canadian or domestic vaccine candidates you assessed. We heard on Tuesday from Providence, as you may well know. They certainly expressed considerable dissatisfaction and disappointment in the type of grant they received through the National Research Council.
Could you just go through some of the thinking that went on, the kind of data that you required at each step of the way, in terms of assessing domestic vaccines, and perhaps particularly Providence itself?